RE: Selling rights21 Mar 2026 08:04
Never come across a company that been on the market so long, that botch things… this is all done on purpose. This is last chance saloon for this company, irrelevant of science. HEMO have overtaken this lot. Bad directors…. But clever. Making themselves a living while PI’s lose money. Over 60p and I’m out.